Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
|
CN |
|
A
|
ASML Holding NV
XMUN:ASME
|
NL |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
PSE:VIG
|
AT |
|
G
|
G Capital PCL
SET:GCAP
|
TH |
|
K
|
Kingspan Group PLC
XMUN:KRX
|
IE |
|
I
|
Infrastrutture Wireless Italiane SpA
F:WI8
|
IT |
Intrinsic Value
Is GU5 undervalued or overvalued?
See the intrinsic value estimate for 
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
GU5 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with GU5’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Guangzhou Baiyunshan Pharmaceutical Does
Guangzhou Baiyunshan Pharmaceutical Holdings is a Chinese healthcare company that makes and sells medicines, health products, and related medical goods. Its business includes prescription drugs, over-the-counter medicines, traditional Chinese medicines, and some health-care and medical packaging products. It also has pharmaceutical distribution and retail activities, so it sits in several parts of the drug supply chain rather than only making finished medicines.
- Headquarters
- China CN
- Employees
- 27 057
- IPO date
- Oct 21, 1997
Revenue & Expenses Breakdown
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
The intrinsic value for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GU5) under the Base Case is hidden EUR.
Compared with the current market price of 1.47 EUR, the stock appears hidden.